Milestone One is pleased to announce a new collaboration with Centro de Oncología de Precisión, part of Celerity Clinical Research’s integrated network of research centers spanning Chile, Peru, Mexico, Colombia, El Salvador, and Spain. This alliance marks a significant step in advancing Milestone One’s ability to expand a globally harmonized network of research institutions that deliver operational excellence and accelerate clinical innovation.

Centro de Oncología de Precisión brings proven expertise in conducting Phase I-III clinical studies across multiple therapeutic areas, supported by standardized operations that adhere to international quality criteria. This approach ensures consistent, reliable, and reproducible data across all affiliated sites. For Milestone One, this collaboration represents a strategic alliance that combines regional reach, multidisciplinary expertise, and reduced site activation timelines, key factors that drive efficiency and predictability in executing complex protocols.

“This collaboration reflects Milestone One’s commitment to building a globally harmonized network of research centers that can execute complex studies with speed, consistency, and quality,” says Lukasz Switek, Global Project Manager. “Centro de Oncología de Precisión brings deep regional expertise and a strong culture of scientific rigor, key elements that will lead to better outcomes for advancing medicine in Latin America.”

Through this collaboration, Centro de Oncología de Precisión serves as a strategic hub for Milestone One in Latin America, enabling access to a consolidated network of research centers that operate under the highest international standards. This multinational presence facilitates accelerated recruitment, diversification of study populations, and optimization of clinical trial timelines. 

“With advanced diagnostic technologies, a robust regulatory compliance framework, and a network of internationally recognized investigators, Centro de Oncología de Precisión exemplifies the innovation and quality that define Milestone One’s global collaborations,” says Jose Miguel Erpel Norambuena, CEO of Celerity Clinical Research.

Supported by dozens of regional Key Opinion Leaders, the collaboration enhances scientific credibility and strengthens the overall impact of clinical research outcomes.

Are you interested in learning more about how Milestone One can help your site manage complexity to take on more studies or get involved in clinical research for the first time?